Brecht, S., Efficacy and safety of duloxetine 60 mg and 120 mg daily in patients hospitalized for severe depression: A double-blind randomized trial (2010) J Clin Psychiatry, , Epub ahead of print
Detke, M.J., Wiltse, C.G., Mallinckrodt, C.H., McNamara, R.K., Demitrack, M.A., Bitter, I., Duloxetine in the acute and long-term treatment of major depressive disorder: A placebo- and paroxetine-controlled trial (2004) European Neuropsychopharmacology, 14 (6), pp. 457-470. , DOI 10.1016/j.euroneuro.2004.01.002, PII S0924977X04000161
Goldstein, D.J., Lu, Y., Detke, M.J., Wiltse, C., Mallinckrodt, C., Demitrack, M.A., Duloxetine in the treatment of depression: A double-blind placebo-controlled comparison with paroxetine (2004) Journal of Clinical Psychopharmacology, 24 (4), pp. 389-399. , DOI 10.1097/01.jcp.0000132448.65972.d9
Gi, P., Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents (2007) Biol Psychiatry, 62, pp. 1217-1227
Gi, P., Treatment of SSRI-resistant depression: A meta-analysis comparing within- Versus across-class switches (2008) Biol Psychiatry, 63, pp. 699-704
Raskin, J., Duloxetine in the long term treatment of major depressive disorder (2003) J Clin Psychiatry, 64, pp. 1237-1244
Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression (2006) N Engl J Med, 354, pp. 1231-1242
Those, M.E., Efficacy of duloxetine and selective serotonin reuptake inhibitors: Comparisons as assessed by remission rates in patients with major depressive disorder (2007) J Clin Psychopharmacol, 27, pp. 672-676
Wernicke, J.F., An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain (2007) Pain Med, 8, pp. 503-513
